The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone ... After four weeks, 22.5% of patients taking Spravato ...

The bridge connects the civilian and military campuses. Black spray paint could be seen on the bridge supports, with some messages linking President Donald Trump to fascist ideology. The words ...

in a study published in the 5.2 impact factor medical journal "Vaccines." The Role Innovative Bioresearch Plays in Pushing DeSci Forward INNBC is drawing the line between "pseudoscience" and ...

Jan. 27, 2025 – After years of limited options, people with hard-to-treat depression finally have a new standalone treatment. The FDA’s latest approval of the nasal spray Spravato (esketamine ...